Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank 指定難病告示番号
1 EDNRA 7件: Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D01227 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
2 EDNRA 7件: Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D07077 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211
3 EDNRA 7件: Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D07538 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
4 EDNRB 6件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer D01227 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
5 EDNRB 6件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer D07538 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
6 NR3C1 1件: Neuroactive ligand-receptor interaction D00407 Methylprednisolone 10件: 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
7 NR3C1 1件: Neuroactive ligand-receptor interaction D00751 Methylprednisolone 10件: 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
8 NR3C1 1件: Neuroactive ligand-receptor interaction D00979 Methylprednisolone 10件: 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
9 NR3C1 1件: Neuroactive ligand-receptor interaction D05000 Methylprednisolone 10件: 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
10 NR3C1 1件: Neuroactive ligand-receptor interaction D05000 Methylprednisolone hemisuccinate 1件: 211
11 NR3C1 1件: Neuroactive ligand-receptor interaction D05001 Methylprednisolone 10件: 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
12 NR3C1 1件: Neuroactive ligand-receptor interaction D05002 Methylprednisolone 10件: 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
13 AR 4件: Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer D00462 Oxandrolone 2件: 211, 285
14 PDE5A 3件: Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway D02229 Sildenafil 17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301
15 PDE5A 3件: Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway D08514 Sildenafil 17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301